US Stock MarketDetailed Quotes
SWTX SpringWorks Therapeutics
- 41.480
- -0.250-0.60%
Close Nov 29 13:00 ET
- 42.607
- +1.127+2.72%
Post 17:01 ET
3.09BMarket Cap-10663P/E (TTM)
41.850High40.850Low645.35KVolume41.360Open41.730Pre Close26.80MTurnover0.93%Turnover RatioLossP/E (Static)74.39MShares53.92052wk High5.79P/B2.87BFloat Cap28.21052wk Low--Dividend TTM69.09MShs Float96.480Historical High--Div YieldTTM2.40%Amplitude13.600Historical Low41.526Avg Price1Lot Size
About SpringWorks Therapeutics Company
Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, Brimarafenib, SW-682, and EGFR Inhibitor. The company was founded in August 2017 and is headquartered in Stamford, CT.
Company Profile
SymbolSWTX
Company NameSpringWorks Therapeutics
Listing DateSep 13, 2019
Issue Price18.00
Founded2017
CEOMr. Saqib Islam, J.D.
MarketNASDAQ
Employees305
Fiscal Year Ends12-31
Address100 Washington Boulevard
CityStamford
ProvinceConnecticut
CountryUnited States of America
Zip Code06902
Phone1-203-883-9490
Websitehttp://www.springworkstx.com
Company Executives
- Name
- Position
- Salary
- Saqib Islam, J.D.
- Director and Chief Executive Officer
- 18.35M
- Tai-An Lin
- Chief Scientific Officer
- --
- Dr. Badreddin Edris, PhD
- Chief Operating Officer
- 6.64M
- Bhavesh Ashar, M.B.A.
- Chief Commercial Officer
- --
- Michael Nofi
- Chief Accounting Officer
- --
- Francis I. Perier, Jr
- Chief Financial Officer
- 3.74M
- Daniel Pichl
- Chief People Officer
- --
- Dr. James Cassidy, M.D.,PhD
- Chief Medical Officer
- 4.31M
- Daniel S. Lynch, M.B.A.
- Chairman of the Board
- 545.14K
- Carlos Alban
- Independent Director
- 507.64K
- Alan Fuhrman
- Independent Director
- 520.14K
- Dr. Freda C. Lewis-Hall,M.D.
- Independent Director
- 508.45K
- Dr. Julie Hambleton, M.D.
- Independent Director
- 520.14K
- Dr. Martin W. Mackay, PhD
- Independent Director
- --
- Herschel S. Weinstein, J.D.
- General Counsel and Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data